NEW PRODUCT DEVELOPMENT
Device
Stryker Corporation
Total Payments
$2.1M
Transactions
5,327
Doctors
1,166
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $477,092 | 1,086 | 383 |
| 2019 | $632,129 | 2,171 | 521 |
| 2018 | $616,795 | 1,899 | 620 |
| 2017 | $372,658 | 171 | 66 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.2M | 570 | 59.4% |
| Travel and Lodging | $591,588 | 1,762 | 28.2% |
| Food and Beverage | $145,367 | 2,951 | 6.9% |
| Unspecified | $100,239 | 17 | 4.8% |
| Gift | $8,605 | 8 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,250 | 11 | 0.3% |
| Royalty or License | $282.53 | 2 | 0.0% |
| Education | $252.63 | 6 | 0.0% |
Payments by Type
General
$2.0M
5,310 transactions
Research
$100,239
17 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| THE SURPASS INTRACRANIAL ANEURYSM EMBOLIZATION SYSTEM PIVOT TRIAL SCENT | Stryker Corporation | $39,614 | 0 |
| Development of a Three-Dimensional Bone Database for Scapula Fractures | Stryker Corporation | $23,033 | 0 |
| RAS Shell | Stryker Corporation | $15,000 | 1 |
| Optimizing Femoral ACL Femoral Tunnel Position with Flexible Curved Reamers | Stryker Corporation | $13,820 | 0 |
| Atlas | Stryker Corporation | $2,450 | 4 |
| Remote Radiographic Review | Stryker Corporation | $1,800 | 1 |
| ANATOMICAL ANALYSIS OF DISEASED PATELLOFEMORAL MORPHOLOGY | Stryker Corporation | $1,169 | 0 |
| PERI-PROSTHETIC IMPLANT AND INSTRUMENT SYSTEM | Stryker Corporation | $1,000 | 0 |
Top Doctors Receiving Payments for NEW PRODUCT DEVELOPMENT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Jacksonville, FL | $113,345 | 20 |
| Santiago Horgan | Surgery | San Diego, CA | $65,179 | 41 |
| , M.D | Neuroradiology | Morgantown, WV | $50,596 | 61 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Cleveland, OH | $31,573 | 35 |
| , M.D | Plastic Surgery | New York, NY | $29,186 | 14 |
| , MD | Orthopaedic Surgery | Salt Lake City, UT | $28,937 | 31 |
| , M.D | Specialist | Tampa, FL | $26,945 | 24 |
| , M.D | Orthopaedic Surgery | Seattle, WA | $25,764 | 36 |
| , M.D | Sports Medicine | Chicago, IL | $25,678 | 7 |
| , MD | Orthopaedic Surgery | Rochester, MN | $25,180 | 62 |
| , MD | Orthopaedic Surgery | Baltimore, MD | $22,729 | 8 |
| , M.D | Surgery | Annapolis, MD | $22,277 | 12 |
| , MD | Orthopaedic Surgery | New York, NY | $21,836 | 28 |
| , MD | Orthopaedic Surgery | Southfield, MI | $21,460 | 37 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Rochester, MN | $21,252 | 62 |
| , D.O | Orthopaedic Surgery | Brighton, MA | $20,809 | 4 |
| , MD | Orthopaedic Surgery | Spokane, WA | $20,607 | 17 |
| , MD | Orthopaedic Surgery | New York, NY | $20,572 | 31 |
| , MD PHD | Orthopaedic Surgery | Los Angeles, CA | $19,877 | 15 |
| , M.D | Orthopaedic Surgery | — | $19,516 | 8 |
| , M.D | Orthopaedic Surgery | Chestnut Hill, MA | $18,896 | 44 |
| , M.D | Orthopaedic Surgery | Phoenix, AZ | $18,489 | 11 |
| , M.D | Sports Medicine | Lone Tree, CO | $18,333 | 17 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Coeur D Alene, ID | $17,153 | 2 |
| , M.D | Diagnostic Radiology | Worcester, MA | $15,334 | 20 |
Ad
Manufacturing Companies
- Stryker Corporation $2.1M
Product Information
- Type Device
- Total Payments $2.1M
- Total Doctors 1,166
- Transactions 5,327
About NEW PRODUCT DEVELOPMENT
NEW PRODUCT DEVELOPMENT is a device associated with $2.1M in payments to 1,166 healthcare providers, recorded across 5,327 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2017 to 2020. In 2020, $477,092 was paid across 1,086 transactions to 383 doctors.
The most common payment nature for NEW PRODUCT DEVELOPMENT is "Consulting Fee" ($1.2M, 59.4% of total).
NEW PRODUCT DEVELOPMENT is associated with 8 research studies, including "THE SURPASS INTRACRANIAL ANEURYSM EMBOLIZATION SYSTEM PIVOT TRIAL SCENT" ($39,614).